Una abeja melífera tiene un cerebro más pequeño que una semilla de sésamo. Y, sin embargo, puede tomar decisiones inteligentes y con suma rapidez. Un robot programado para hacer igual de bien todo el trabajo de una abeja necesitaría estar conectado telemátic …
¿Por qué en algunas cosas una abeja es tan inteligente como una supercomputadora? Read More »
Una nueva célula solar de perovskita, que permite que la luz solar llegue a ambos lados del dispositivo, tiene el potencial de producir mayores rendimientos energéticos con menores costes totales, según una investigación reciente. Las células solares de pe …
Atrás quedan los tiempos donde al viajar en avión a cualquier parte del mundo uno podía disfrutar de suculentos platos viajando en clase turista. Hoy la oferta gastronómica ha disminuido considerablemente. El Covid ha hecho mella en los precios de los billetes de …
El ahorro de energía y dinero en la gastronomía aérea Read More »
Since April, the CMS has halted Medicaid eligibility checks in 12 states to address issues causing procedural disenrollments, according to officials.
CMS pausing Medicaid redeterminations in states noncompliant with renewal requirements Read More »
At almost 80,000 square feet, the addition will allow the Japan-based to create jobs for in-office and hybrid workers in the region.
Zynex, Inc. will hold a conference call on Thursday, July 27, 2023 at 4:15 PM Eastern Time to discuss its financial results for the second quarter, 2023 ended June 30, 2023.
Zynex, Inc. Sets Second Quarter 2023 Earnings Call Read More »
Schrödinger, Inc. today reported that on July 14, 2023, the company granted (i) non-statutory stock options to purchase 10,250 shares of the company’s common stock to nine newly hired employees and (ii) restricted stock units (RSUs) with respect to 6,225 shares of the company’s common stock to nine newly hired employees.
Rarecells is thrilled to announce its breakthrough publication, written in partnership with the team of Dr. Azra Raza from Columbia University Irving Medical Center, revealing for the first time the presence of circulating giant cancer cells (CGCCs) in patients with Myelodysplastic Syndrome (MDS).
With Eisai and Biogen’s Leqembi now fully approved, researchers are exploring combinations—including with therapies targeting tau and microglial function—that could increase its effectiveness.
Exploring Leqembi Combinations in the Fight Against Alzheimer’s Read More »
Endo International plc (OTC: ENDPQ) announced today that the first patient has been enrolled in CURVE-PD (Clinical Understanding through Real-world data to Validate Effectiveness of treatments in Peyronie’s disease), a non-interventional registry of up to 1,000 patients with Peyronie’s disease (PD).
Endo Announces First Patient Enrolled in Registry of Peyronie’s Disease Read More »
